Real World Data

Collecting, Real-World. Data.

From real life care to decision ready Market Access Intelligence—ethically, compliantly, at global scale
Clinical trials are just one chapter in a medicine’s story. To truly understand its impact, we must also look at how it performs in the real world. Collecting Real-World Data (RWD) through a Managed Access Program opens a unique window of opportunity, especially when medicines are not yet licensed.
Who Benefits
• Pharmaceutical Innovator Companies – Identify early demand before product launch and sharpen evidence plans.
• Market Access & Consulting Firms – Gain credible inputs for forecasting, pricing, and policy strategy.
• Regulators & NGOs – Understand therapy gaps and equity issues to support advocacy and reimbursement frameworks.
• Distributors & Access Programs – Spot new growth markets, emerging prescriber demand, and unmet needs in real time.

What we offer:-

RWD, Clinical Trials.

img

Real World Observation:- For unlicensed or early-access therapies, real-world information is limited. Managed/Expanded/Named Patient Programs (where permitted) create the first window to see how a medicine performs in routine care beyond controlled trials—yielding early, pragmatic insights that guide next-step evidence plans.

img

Access program DNA( expertise): Experience embedding low burden, compliant RWD capture within Managed/Expanded/Named Patient Programs (MAP/EAP/NPP) where permitted.

img

Therapeutic depth: We work across various therapeutic areas and care settings, adapting to heterogeneous real-world practice patterns.

img

Reimbursement and Market Strategy: Stakeholders need evidence to optimizes access strategies, drive reimbursement decisions and sharpens launch positioning. RWD informs pricing, access, and market positioning.

How We Support This Journey

Actionable Insights & Compliance First

img

Actionable Insights: Our analytics team transforms raw entries into clear, strategic reports that support decision-making at critical points in a program.

img

Compliance First: Every dataset is anonymized, ethically collected, and aligned with international standards .

img

Email/WhatsApp: info@ikrispharmanetwork.com
TOLLFREE: 18008891064